Puma Biotechnology (NASDAQ:PBYI – Get Free Report) had its price objective boosted by equities researchers at TD Cowen from $5.00 to $6.00 in a research report issued to clients and investors on Friday,Benzinga reports. Get Puma Biotechnology alerts:Get Our Latest Stock Analysis on PBYIPuma Biotechnology Stock Up 9.7%Shares of PBYI stock traded up $0.79 during trading hours on Friday, hitting $8.91. Puma Biotechnology (NASDAQ:PBYI – Get Free Report) last announced its earnings results on Thursday, August 6th. As a group, equities research analysts expect that Puma Biotechnology will post 0.28 EPS for the current fiscal year. Further ReadingReceive News & Ratings for Puma Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puma Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.